These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 18042068

  • 1. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E.
    Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
    [Abstract] [Full Text] [Related]

  • 2. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
    Fu XR, Zhang C, Chen CY, Zhang L, Wang LX, Wang BH, Liu XY, Zhang MZ.
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
    [Abstract] [Full Text] [Related]

  • 3. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
    Zhou CY, Yao JF, Chen XD.
    Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
    [Abstract] [Full Text] [Related]

  • 4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 5. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H.
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [Abstract] [Full Text] [Related]

  • 6. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN.
    Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
    [Abstract] [Full Text] [Related]

  • 8. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N, Nagane Y, Hirakata H, Ichinose T, Okada Y, Yamaguchi K, Takahashi S.
    Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M, Topolcan O, Holubec L, Rupert K, Cerna M, Holubec LS, Treska V, Finek J, Cerny R.
    Anticancer Res; 2007 Jun; 27(4A):1863-7. PubMed ID: 17649785
    [Abstract] [Full Text] [Related]

  • 10. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [Abstract] [Full Text] [Related]

  • 11. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 12. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D, Boricic I, Todorovic V, Tomanovic N, Radojevic S.
    Br J Dermatol; 2005 Dec 15; 153(6):1166-75. PubMed ID: 16307653
    [Abstract] [Full Text] [Related]

  • 13. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M, Holubec L, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R.
    Anticancer Res; 2005 Dec 15; 25(5):3387-91. PubMed ID: 16101153
    [Abstract] [Full Text] [Related]

  • 14. Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma.
    Roh MR, Zheng Z, Kim HS, Kwon JE, Jeung HC, Rha SY, Chung KY.
    Exp Mol Pathol; 2012 Apr 15; 92(2):236-42. PubMed ID: 22305927
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
    Suminoe A, Matsuzaki A, Hattori H, Koga Y, Ishii E, Hara T.
    Leuk Res; 2007 Oct 15; 31(10):1437-40. PubMed ID: 17350093
    [Abstract] [Full Text] [Related]

  • 16. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
    Giannopoulos G, Pavlakis K, Parasi A, Kavatzas N, Tiniakos D, Karakosta A, Tzanakis N, Peros G.
    Anticancer Res; 2008 Oct 15; 28(3B):1875-81. PubMed ID: 18630474
    [Abstract] [Full Text] [Related]

  • 17. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS, Chen MZ, Wang HJ, Ke CL, Yan C, Zheng H, Hong YS.
    Ai Zheng; 2002 Oct 15; 21(10):1124-8. PubMed ID: 12508658
    [Abstract] [Full Text] [Related]

  • 18. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H, Lin QD, Qiao C.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug 15; 41(8):509-13. PubMed ID: 17083831
    [Abstract] [Full Text] [Related]

  • 19. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.
    Clin Cancer Res; 2004 Jul 15; 10(14):4746-53. PubMed ID: 15269148
    [Abstract] [Full Text] [Related]

  • 20. [Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].
    Guo W, Chen G, Zhu C, Wang H.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct 15; 37(10):604-7. PubMed ID: 12487935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.